# TEOSYAL® RHA Global Action, TEOSYAL® RHA Deep Lines, and Juvéderm® Ultra XC for the Correction of Nasolabial Folds

> **NCT02195427** · NA · COMPLETED · sponsor: **Teoxane SA** · enrollment: 148 (actual)

## Conditions studied

- Nasolabial Folds, Wrinkles

## Interventions

- **DEVICE:** TEOSYAL® RHA Global Action
- **DEVICE:** TEOSYAL® RHA Deep Lines

## Key facts

- **NCT ID:** NCT02195427
- **Lead sponsor:** Teoxane SA
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-06
- **Primary completion:** 2015-03
- **Final completion:** 2016-03
- **Target enrollment:** 148 (ACTUAL)
- **Last updated:** 2018-04-25

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02195427

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02195427, "TEOSYAL® RHA Global Action, TEOSYAL® RHA Deep Lines, and Juvéderm® Ultra XC for the Correction of Nasolabial Folds". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT02195427. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*